Anastasios Kollias Selected Research

Insulin Resistance

3/2014	Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation.
10/2010	Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism.
2/2010	Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes.
5/2009	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasios Kollias Research Topics

Disease

18	Hypertension (High Blood Pressure) 11/2023 - 02/2014
10	COVID-19 05/2023 - 01/2020
4	Insulin Resistance 03/2014 - 05/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 05/2009
3	Atherosclerosis 01/2021 - 02/2010
3	Inflammation (Inflammations) 01/2021 - 03/2014
3	Atrial Fibrillation 01/2020 - 11/2012
3	Overweight 01/2019 - 01/2011
3	Obesity 01/2019 - 01/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2012 - 02/2010
2	Neoplasms (Cancer) 07/2022 - 12/2009
2	Hemorrhage 01/2022 - 01/2021
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2014 - 01/2014
2	Hyperthyroidism 10/2010 - 03/2008
1	Ischemic Stroke 04/2024
1	Transient Ischemic Attack 04/2024
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Thrombosis (Thrombus) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Hyperglycemia 10/2023
1	Hypokalemia 09/2023
1	Reinfection 10/2022
1	Human Influenza (Influenza) 07/2022
1	Dyspnea (Shortness of Breath) 11/2021
1	Fever (Fevers) 11/2021
1	Pleural Effusion (Pleural Effusions) 11/2021
1	Pneumonia (Pneumonitis) 09/2021
1	Sepsis (Septicemia) 01/2020
1	Abdominal Obesity 01/2020
1	Pediatric Obesity 04/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2014
1	White Coat Hypertension 09/2014
1	Necrosis 02/2013
1	Margins of Excision 09/2011
1	Hypothyroidism 05/2009
1	Endometriosis 07/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2009
4	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 03/2008
4	AdiponectinIBA 03/2014 - 02/2011
3	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 08/2014
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2011
3	HDL CholesterolIBA 01/2020 - 01/2011
3	Adiponectin ReceptorsIBA 07/2012 - 02/2010
2	Immune Checkpoint InhibitorsIBA 01/2024 - 07/2022
2	Monoclonal AntibodiesIBA 05/2023 - 10/2022
2	Messenger RNA (mRNA)IBA 05/2022 - 07/2012
2	MercuryIBA 04/2022 - 11/2012
2	AnticoagulantsIBA 01/2020 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2020
2	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2019 - 10/2014
2	AlbuminsIBA 12/2014 - 02/2014
2	C-Reactive ProteinIBA 10/2014 - 03/2014
2	AdipokinesIBA 03/2014 - 02/2013
2	LeptinIBA 03/2014 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 07/2012 - 02/2010
2	Insulin (Novolin)FDA Link 10/2010 - 05/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	DiureticsIBA 09/2023
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2023
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 09/2023
1	tocilizumab (atlizumab)FDA Link 05/2023
1	interleukin-6 receptor alphaIBA 05/2023
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2022
1	BNT162 VaccineIBA 05/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Moxifloxacin (Avelox)FDA Link 11/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2021
1	Interleukin-1 (Interleukin 1)IBA 09/2021
1	Immunomodulating AgentsIBA 09/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2021
1	SodiumIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2020
1	ORALIT (ORS)IBA 01/2019
1	LipidsIBA 04/2017
1	Metformin (Glucophage)FDA LinkGeneric 10/2014
1	Oral ContraceptivesIBA 10/2014
1	Advanced Glycation End ProductsIBA 01/2014
1	ResistinIBA 02/2013
1	Cell Adhesion MoleculesIBA 12/2009
1	Protein Isoforms (Isoforms)IBA 03/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2008
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2008

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2020
8	Blood Pressure Monitors 11/2023 - 11/2012
1	Immunotherapy 01/2024
1	Drug Therapy (Chemotherapy) 01/2024
1	Duration of Therapy 01/2024
1	Glycemic Control 10/2023
1	Immunomodulation 05/2023
1	Contraindications 01/2022
1	Ambulatory Care (Outpatient Care) 11/2021
1	Diet Therapy (Therapy, Diet) 01/2014
1	Prostatectomy (Retropubic Prostatectomy) 09/2011
1	Cystectomy 07/2006